nanofitins for cancer(Pfizer)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namenanofitins for cancer(Pfizer)
Drug Alias Namenanofitins for cancer(BIND Therapeutics/Affilogic)nanofitins for cancer(DNIB Unwind/Affilogic)
ClassificationBiologics
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDNIB Unwind Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffilogic LaboratoriesDNIB Unwind IncPfizer Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A